https://regulatorynews.com/daraxonrasib-first-ras-inhibitor-pancreatic-cancer Regulatory News en 2026-10-17T10:50:36-04:00 EMA Recommends First RAS Inhibitor for Pancreatic Cancer https://regulatorynews.com/ascendis-pharma-yuviwel-achondroplasia-chmp-opinion Regulatory News en 2026-10-17T09:39:56-04:00 Ascendis Wins CHMP Backing for Achondroplasia Drug Yuviwel https://regulatorynews.com/centinel-spine-prodisc-c-nova-two-level-approval Regulatory News en 2026-10-17T09:39:56-04:00 Centinel Spine Completes 2-Level Cervical Disc Set https://regulatorynews.com/marengo-therapeutics-invikafusp-alfa-fast-track-expansion Regulatory News en 2026-10-17T09:39:56-04:00 Marengo Earns Second FDA Fast Track for Tumor Drug https://regulatorynews.com/ema-rasonque-chmp-opinion Regulatory News en 2026-10-17T05:58:51-04:00 EMA Recommends EU Approval for RAS-Inhibitor Rasonque https://regulatorynews.com/enspryng-ted-at-home-approval Regulatory News en 2026-10-17T05:58:51-04:00 FDA Approves Enspryng as First At-Home TED Treatment https://regulatorynews.com/par-health-argatroban-recall Regulatory News en 2026-10-17T05:58:51-04:00 Par Health Recalls Argatroban Over Particulate Matter https://regulatorynews.com/edwards-sapien-m3-delivery-alert Regulatory News en 2026-10-16T10:47:44-04:00 FDA Flags Edwards SAPIEN M3 Delivery System After Death https://regulatorynews.com/e2-helo-return-fda-clearance Regulatory News en 2026-10-16T09:53:32-04:00 E2 Clears FDA Hurdle for Blood-Saving Clot Device https://regulatorynews.com/iambic-therapeutics-nasdaq-ipo Regulatory News en 2026-10-16T09:53:32-04:00 Iambic Prices $150M IPO to Fund AI-Built Cancer Drug https://regulatorynews.com/souffle-therapeutics-series-b-financing Regulatory News en 2026-10-16T09:53:32-04:00 Soufflé Raises $135M to Push RNA Drug Into the Clinic https://regulatorynews.com/fyb206-keytruda-biosimilar-bla Regulatory News en 2026-10-16T05:57:35-04:00 FDA Accepts First Keytruda Biosimilar for Review https://regulatorynews.com/mhra-strategy-2030 Regulatory News en 2026-10-16T05:57:35-04:00 MHRA Publishes Strategy 2030 for the AI Era https://regulatorynews.com/olympus-fda-warning-letter Regulatory News en 2026-10-16T05:57:35-04:00 Olympus Discloses New FDA Warning Letter Over QMS